American Board of Regenerative Medicine Japan Chapter
Helene has been appointed to the Japanese chapter of the American Board of Regenerative Medicine.
Tokyo, February 28, 2024 — As a true pioneer in the field of regenerative medicine in Japan, Omotesando Helene Clinic has announced its official designation as the nation’s sole accredited institution by the American Board of Regenerative Medicine. This prestigious honor underscores our unwavering commitment to delivering cutting-edge regenerative medical services, solidifying our position as a leading force in the industry, particularly within Asia. Omotesando Helene Clinic continually pushes the boundaries of medical science to elevate patient care, demonstrating exceptional expertise and innovation in stem cell therapies and advanced regenerative techniques. This milestone recognition further reflects our influential role in setting new benchmarks of excellence across the global medical community.
Our Commitment to Global and Local Health
Leveraging its newly appointed status as an accredited institution, Omotesando Helene Clinic stands at the absolute forefront of promoting safe, effective, and ethically responsible practices in regenerative medicine. Through strategic collaboration with global regulatory frameworks, we ensure that patients across Asia have direct access to advanced treatments that comply strictly with rigorous international standards.
Dr. Matsuoka, CEO of Omotesando Helene Clinic, remarked:
"This milestone achievement is a powerful testament to our team’s dedication, hard work, and relentless passion for innovating patient care through regenerative medicine. Being recognized as the sole accredited institution in Japan is not only a profound honor, but a responsibility we approach with the utmost seriousness. Our defining goal remains to aggressively drive innovation while unyieldingly ensuring patient safety and the absolute highest quality of care."
By broadening the horizons of regenerative medicine, Omotesando Helene Clinic’s recent accreditation unlocks extraordinary opportunities for pan-Asian and global research, academic collaboration, and clinical trials, heralding a transformative new era in healthcare. In this new era, patients can look forward to highly personalized, advanced therapies that masterfully harness the body’s natural regenerative capabilities. We warmly welcome forward-thinking partners, affiliates, and patients alike to join us in this pioneering journey to drive next-generation initiatives and collaborations across the regenerative medicine landscape. Through our collective efforts, we look forward to establishing new benchmarks of excellence, accelerating medical breakthroughs, and profoundly transforming lives through our unwavering commitment to care and innovation.
ABRM
» https://ambrm.org/
